Top 100 Countries by Health Expenditure per Capita (PPP), Latest Official Data

How health spending per person is distributed across the Top 100 countries

Health expenditure per capita in PPP terms shows how many current healthcare resources are spent for each resident after adjusting for price-level differences across countries. It is one of the clearest ways to compare the financial scale of health systems. For this ranking, the table uses the latest official value available for each country in the World Bank indicator SH.XPD.CHEX.PP.CD, which is sourced from the WHO Global Health Expenditure Database.

The top of the ranking is led by the United States, Western Europe, several wealthy small European states and a smaller group of other high-income systems such as Singapore, Japan, South Korea and Australia. Even Rank 100 still stands above 1,064.08 PPP dollars per person, which shows how large the gap remains between the spending frontier and the lower edge of this Top 100.

• #1 United States — 13,473.19 PPP dollars per person. The U.S. remains the clear outlier in absolute per-capita health spending.
• #2 Switzerland — 10,601.93. Switzerland stays at the very top of the non-U.S. group, reflecting a very high-cost, high-resource health system.
• #3 Monaco — 9,797.17. Small, very high-income states remain prominent in per-capita comparisons because spending is spread across a small population base.
• #4 Liechtenstein — 9,795.16. Another microstate near the frontier, showing how compact, wealthy systems can rank extremely high on a per-person basis.
• #5 Norway — 9,523.31. Norway combines high income, large public financing capacity and strong service depth.

Full Top 100 ranking

The table below contains all 100 rows directly in the HTML. It is ranked by the latest official PPP-adjusted health expenditure per capita value available for each country in the World Bank series. Because reporting years differ, the ranking should be read as a latest official snapshot, not as a single-year synchronized release.

What the ranking actually shows

This ranking is about the financial scale of health systems, not about overall system quality. A country can spend more per person because it funds broad coverage and advanced care, but it can also spend more because health services, pharmaceuticals, labour and administration are simply more expensive. That is why the United States remains the clearest example of a system that sits far above everyone else on spending without leading every outcome comparison by the same margin.

The distribution also shows a clear structural pattern. The upper part of the Top 100 is filled with high-income countries and microstates. The middle of the table is dominated by Southern, Central and Eastern Europe, the Gulf, Latin America and richer Asian systems. The lower boundary of the Top 100 sits just above one thousand PPP dollars per person, which means that many countries outside this page still operate at a much lower spending level.

FAQ

• Why is the United States so far ahead? Because the U.S. combines very high service prices, high administrative costs and a very large overall health spending base.
• Why are microstates so high in the ranking? In very small, wealthy countries, a large health-spending envelope divided by a small population can produce extremely high per-capita values.
• Why is the latest year not the same for every country? International health expenditure data are published with country-specific reporting lags, so a latest official snapshot is more honest than forcing all countries into one common year label.
• Does a high ranking mean better health outcomes? Not automatically. Outcomes depend on system design, prevention, public health, demographics and how efficiently spending is converted into services.
• Why use PPP dollars instead of current US dollars? PPP adjustment makes cross-country comparisons more meaningful by accounting for differences in domestic price levels.